…itis (LN) relapse in relation to LN induction treatment without Cyclophosphamide (Non-Cyc) or with Cyclophosphamide (Cyc) (A). Boxplots of methy…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 200 of 2459…Objectives Cognitive impairment (CI) is common in people with systemic lupus erythematosus (pwSLE) and negatively impacts quality of life. The underlying …
…stinct clinical phenotype which may differ from smoking-related COPD. They may therefore need to be treated and followed differently…
…al bone damage over 48 months in patients with PsA treated with secukinumab, suggesting that anti-IL-17A therapy induces sustained osteopro…
…mbosis or venous thrombosis, breast cancer, endometrial cancer, ovarian cancer, previous use of menopausal hormone therapy, or previous bilate…
…to −4.0) and small effects in hand (−10.0 95% CI −15.5 to −4.5) osteoarthritis. Varying certainty evidence indicated comparable outcomes to ed…
…64–0.74) p<0.001, Tau 2 0.03, I2 71%). Older patients receiving beta-blockers were more likely to develop bradycardia (RR 3.98 (2.72–5.82), p…
…shoftu Hospital in Ethiopia. The study involved 130 people with DR-TB from January to May 2023.Participants All adult people on DR-TB…
…is study received approval from the medical ethics committee of Kansai Medical University. The results will be submitted for publication in an internatio…
…li, intestinal spirochaetosis) characteristics seen in MSM with E. vermicularis.Conclusion Although limited, this review provides some useful i…
… but were attenuated in intention-to-treat analyses.Conclusions Clozapine initiators had an elevated risk of neutropenia-related hospital…
…o evaluate the efficacy of vascular-targeted pharmacotherapies (statins, phosphodiesterase-4 inhibitors, long-acting bronchodilators). …